Scott Rocklage is managing Partner 5-Am Ventures. This is a position that Rocklage has held since 2004. Scott Rocklage has over two decades health care experience. Mr. Rocklage has Strategic Management experience which has served him very well over the past 20 years.
Due to Scott Rocklage and his efforts, he is responsible for three new United States drug applications. In addition, Rocklage has been involved with conducting clinical drug trials. Clinical drug trials are necessary to test a new drug before it is approved for sale and learn more about Scott.
At present, Rocklage is Board Chairman at Achaogen, Semprus and Relypsa. In addition, Scott Rocklage also holds board positions at Wave-Rx, Variation as well as Pulmatrix. Scott Rocklage is also affiliated with the Whitehead Institute. Scott Rocklage is currently on the Board of Associated at the Whitehead Institute and more information click here.
Earlier in Scott Rocklage career he was CEO of Cubist Pharmaceuticals. In addition, Rocklage also head a CEO position with Nycomed. Dr. Rocklage also has extensive R&D Experience. Research and development is something that helped Rocklage advance his career.
Scott Rocklage received his B.S. in Chemistry from University of California (Berkeley). After graduating from UCLA, Scott Rocklage went on to receive his PHD in Chemistry from the Massachusetts Institute of Technology. Scott Rocklage is based within the Waltham Mass area.
It seems Scott Rocklage makes a success of his business ventures through hard work, drive as well as determination. Rocklage also places great emphasis on the importance of education. Scott Rocklage certainly has some impressive educational credentials and Scott’s lacrosse camp.